Supriya Lifescience Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-02-10
Analyst
Invexa Capital
Equibles does not estimate personal net worth.
Karan is recorded as Analyst at Invexa Capital. Karan has spoken on 1 earnings call across 1 company, most recently for Supriya Lifescience Limited on February 10, 2026. The companies whose calls Karan spoke on are classified in the Healthcare sector.
“So my question is largely on the GLP side. So we were contemplating to enter into the fill-finish side of the GLP. So where are we in that business or on that plan?”
Invexa Capital
Analyst
Transcript header (unverified)
Supriya Lifescience Limited
Biotechnology · Healthcare
Supriya Lifescience Limited Q3 FY '26 Earnings Conference Call
Supriya Lifescience Limited